These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37240366)

  • 1. CRISPR-Mediated In Situ Introduction or Integration of
    Tang Q; Hu Z; Zhao J; Zhou T; Tang S; Wang P; Xiao R; Chen Y; Wu L; Zhou M; Liang D
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
    Morishige S; Mizuno S; Ozawa H; Nakamura T; Mazahery A; Nomura K; Seki R; Mouri F; Osaki K; Yamamura K; Okamura T; Nagafuji K
    Int J Hematol; 2020 Feb; 111(2):225-233. PubMed ID: 31664646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model.
    Luce E; Steichen C; Allouche M; Messina A; Heslan JM; Lambert T; Weber A; Nguyen TH; Christophe O; Dubart-Kupperschmitt A
    Hepatology; 2022 Apr; 75(4):866-880. PubMed ID: 34687060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired CRISPR/Cas9 Nickases Mediate Efficient Site-Specific Integration of
    Wang Y; Zhao J; Duan N; Liu W; Zhang Y; Zhou M; Hu Z; Feng M; Liu X; Wu L; Li Z; Liang D
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of a Hemophilia B Mouse Model with Platelet-Targeted Expression of Factor IX Padua.
    Li B; Wu Z; Xu W; Han W; Liu J; Wang D; Zhang G
    Hum Gene Ther; 2021 May; 32(9-10):506-516. PubMed ID: 33764159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology.
    Ma Y; Sun W; Zhao L; Yao M; Wu C; Su P; Yang L; Wang G
    Stem Cell Res Ther; 2022 Jul; 13(1):353. PubMed ID: 35883203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency).
    Sekayan T; Simmons DH; von Drygalski A
    Expert Opin Biol Ther; 2023; 23(12):1173-1184. PubMed ID: 37962325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.
    Crudele JM; Finn JD; Siner JI; Martin NB; Niemeyer GP; Zhou S; Mingozzi F; Lothrop CD; Arruda VR
    Blood; 2015 Mar; 125(10):1553-61. PubMed ID: 25568350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.
    Martorell L; Luce E; Vazquez JL; Richaud-Patin Y; Jimenez-Delgado S; Corrales I; Borras N; Casacuberta-Serra S; Weber A; Parra R; Altisent C; Follenzi A; Dubart-Kupperschmitt A; Raya A; Vidal F; Barquinero J
    J Thromb Haemost; 2017 Nov; 15(11):2188-2197. PubMed ID: 28834196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
    Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
    Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration.
    Chen X; Niu X; Liu Y; Zheng R; Yang L; Lu J; Yin S; Wei Y; Pan J; Sayed A; Ma X; Liu M; Jing F; Liu M; Hu J; Wang L; Li D
    J Genet Genomics; 2022 Dec; 49(12):1114-1126. PubMed ID: 35691554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B.
    Wang X; Tang N; Shen N; Zhu Y; Lu Y; Gao L
    Hematology; 2020 Dec; 25(1):484-488. PubMed ID: 33295842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
    Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
    Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells.
    Hiramoto T; Kashiwakura Y; Hayakawa M; Baatartsogt N; Kamoshita N; Abe T; Inaba H; Nishimasu H; Uosaki H; Hanazono Y; Nureki O; Ohmori T
    Commun Med (Lond); 2023 Apr; 3(1):56. PubMed ID: 37076593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
    Konkle BA; Walsh CE; Escobar MA; Josephson NC; Young G; von Drygalski A; McPhee SWJ; Samulski RJ; Bilic I; de la Rosa M; Reipert BM; Rottensteiner H; Scheiflinger F; Chapin JC; Ewenstein B; Monahan PE
    Blood; 2021 Feb; 137(6):763-774. PubMed ID: 33067633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B.
    Odaira K; Kawashima F; Tamura S; Suzuki N; Tokoro M; Hayakawa Y; Suzuki A; Kanematsu T; Okamoto S; Takagi A; Katsumi A; Matsushita T; Shima M; Nogami K; Kojima T; Hayakawa F
    Thromb Res; 2022 May; 213():91-96. PubMed ID: 35313235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.
    Khan MTM; Naz A; Ahmed J; Shamsi T; Ahmed S; Ahmed N; Imran A; Farooq N; Khan MTH; Taj AS
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):741-748. PubMed ID: 28752769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B.
    Lu L; Wang L; Shen W; Fang S; Zhao L; Hu X; Yang L; Wang G
    Mol Genet Genomic Med; 2023 May; 11(5):e2147. PubMed ID: 36795372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.